European Society of Toxicology In Vitro

The European Society of Toxicology In Vitro (#ESTIV), congratulates to Kirsten Veltman who has been selected as the recipient of the ESTIV Best poster presentation at the #EUROTOX2023 Congress in Ljubljana, Slovenia

ESTIV Celebrates exceptional researchers presenting their science at the 12th World Congress on Alternatives and Animal Use in the Life Sciences in Canada.

ESTIV 2022 Virtual Special Issue (VSI) was published by the journal Toxicology in Vitro

The abstract submission is now open for the next edition of the ESTIV Congress, which will be held in Prague from June 3-6, 2024! The Abstract submission has been extended by October 31, 2023

Pepper, the Public-private platform for the validation of endocrine disruptors characterization methods, is looking for methods to be validated. PEPPER focuses on test methods that characterise endocrine disrupters substances

Please be aware, that ESTIV and many other EU-based societies are currently facing the incased activity of scams and fraudulent e-mails requesting bank transfers to various accounts. ….

The 8th ESTIV Applied Training Course took place from 29 May to 2 June at the Institute of Experimental Pharmacology and Toxicology, Centre for Experimental Medicine (CEM SAV). The course focused on innovative approaches to toxicity assessment using in vitro and in silico procedures. Sixteen young scientists from eight European countries and Turkey participated in the course.

Two ESTIV travel grants for participation in the JRC Summer School on “Non-Animal Approaches in Science: Challenges and Future Directions

We’re excited to announce that registration is now open for the upcoming joint ASCCT-ESTIV webinar titled “The Latest in Liver Toxicity Assessment In Vitro,” which will feature presentations by Magnus Ingelman-Sundberg, PhD, BSc.Med from the Karolinska Institutet, and Mathieu Vinken, PhD, PharmD, ERT from Vrije Universiteit Brussel.

Join us on Friday, Arpil 28 to learn about the Development of an adverse outcome pathway for kidney tubular necrosis and Computational modelling of neural tube closure defects!